EFFECTIVENESS OF 3% VS 7% HYPERTONIC SALINE NEBULISATION IN ACUTE BRONCHIOLITIS IN CHILDRE
Not Applicable
- Conditions
- Health Condition 1: J219- Acute bronchiolitis, unspecified
- Registration Number
- CTRI/2023/01/048643
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All children from 2 months to 2 years clinically diagnosed with acute
bronchiolitis will be included in the study
Exclusion Criteria
Children with Chronic cardiopulmonary disease viz. congenital heart disease,
cystic lung disease, etc
Preterm birth or history of mechanical ventilation in the neonatal period
Infants who received bronchodilators within two hours of presentation
Children with Family history of asthma
Infants who received oral or inhaled corticosteroids during the preceding 2
weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of Hospital Stay (LHS) and <br/ ><br>improvement in the modified bronchiolitis scoreTimepoint: Modified bronchiolitis score will be assessed at regular intervals of time . Length of hospital stay varies from patient to patient
- Secondary Outcome Measures
Name Time Method need and duration of <br/ ><br>supplemental oxygen <br/ ><br>occurrence of adverse eventsTimepoint: Need for supplemental oxygen will be assessed during the course of stay . Any adverse effects occuring during the course of stay will be monitored and documented and appropriate treatment will be given .